Binzhong Li

Binzhong Li is a Senior Scientist at Fate Therapeutics Inc since March 2022, with prior experience as a Senior Scientist at Adagene from February 2021 to March 2022, where leadership in assay development and validation projects was demonstrated across immunotherapy, oncology, and monoclonal antibody drug disciplines. Binzhong Li's earlier role as Project Scientist at Ludwig Cancer Research involved applying innovative technologies to study cancer-related mechanisms, alongside postdoctoral research that explored DNA damage response and genome instability. Previous postdoctoral work at the Chinese Academy of Sciences focused on the biochemical mechanisms of active DNA demethylation in mammals. Binzhong Li holds a PhD in Biochemistry from the Chinese Academy of Sciences and a BS in Biotechnology from Harbin Institute of Technology.